Showing results (1301-1310 of 1,345) with videos related to

Sort By:
Pageof 135
Science Translational Medicine|September 18, 2015
Durable sequence stability and bone marrow tropism in a macaque model of human pegivirus infectionAdam L Bailey, Michael Lauck, Mariel Mohns, et al.
Scientific Data|July 29, 2023
Multimodal neuroimaging data from a 5-week heart rate variability biofeedback randomized clinical trialHyun Joo Yoo, Kaoru Nashiro, Jungwon Min, et al.
Iscience|April 23, 2025
Fate plasticity of interneuron specificationMohammed A Mostajo-Radji, Walter R Mancia Leon, Arnar Breevoort, et al.
Ebiomedicine|May 13, 2025
An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primatesBeryl B Cummings, Page R Bouchard, Mark N Milton, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
Journal of Virological Methods|April 7, 2025
Comparison of EBOV GP IgG antibody reactivity: Results from two immunoassays in the Democratic Republic of the CongoSydney Merritt, Megan Halbrook, Jean Paul Kompany, et al.
Contemporary Clinical Trials Communications|May 29, 2026
Protocol for Neuro-Oncology Anywhere: Deploying Mayo Clinic's remote cognitive assessment battery and wearable device monitoring platform while assessing the impact of metformin on cognition and quality of life in patients with history of cranial radiationUgur Sener, Bryan Neth, Taylor Galloway, et al.
Plos Pathogens|December 8, 2016
Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus ReplicationAdam J Ericsen, Michael Lauck, Mariel S Mohns, et al.
Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate CancerDaniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
Pageof 135